Pharmacological characterization of the effects of dopamine D1 agonists on eye blinking in rats

Behavioural Pharmacology

Volumn 18, Issue 8, 2007, Pages 745-754

  Desai, Rajeev I ^a   Neumeyer, John L ^b   Bergman, Jack ^a,b   Paronis, Carol A ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b Brain Research Laboratories Inc   (United States)

Author keywords

Dopamine D1 like receptor; Eye blinking; Rat; SKF 82958; SKF 83959

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; FENOLDOPAM; MCL 202; MCL 204; MCL 206; MCL 207; MCL 209; METHAMPHETAMINE; NAXAGOLIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG STRUCTURE; EYELID REFLEX; FEMALE; NONHUMAN; RAT;

ANIMALS; BENZAZEPINES; BLINKING; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1;

EID: 35948979289     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3282f14ee6     Document Type: Article

References (51)

1. Andringa G, Stoof JC, Cools AR (1999a). Sub-chronic administration of the dopamine D1 antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia. Psychopharmacology 146:328-334.
2. Andringa G, Drukarch B, Leysen JE, Cools AR, Stoof JC (1999b). The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors. Eur J Pharmacol 364:33-41.
3. Arnt J, Hyttel J, Sanchez C (1992). Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213:259-267.
4. 1 agonists. In: Harris L, editor. NIDA Research monographs Vol. 119. Washington, DC: NIDA Research Monographs. pp. 185-189.
5. Bergman J, Kamien JB, Spealman RD (1990). Antagonism of cocaine self-administration by selective dopamine D(1) and D(2) antagonists. Behav Pharmacol 1:355-363.
6. Bergman J, Rosenzweig-Lipson S, Spealman RD (1995). Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior in squirrel monkeys. J Pharmacol Exp Ther 273:40-48.
7. A-ergic ligands. Psychopharmacology 153:67-84.
8. 2-like agonists in rats that self-administrer cocaine. J Pharmacol Exp Ther 291:353-360.
9. Cools AR, Lubbers L, van Oosten RV, Andringa G (2002). SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals? Neuropharmacology 42:237-245.
10. Corrigall WA, Coen KM (1991). Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol Biochem Behav 39:799-802.
11. Daly SA,Waddington JL (1992). D-1 dopamine receptors and the topography of unconditioned motor behaviour: studies with the selective, 'full efficacy' benzazepine D-1 agonist SKF 83189. J Psychopharmacol 6:50-60.
12. Desai RI, Terry P, Katz JL (2003). Comparison of the discriminative- stimulus effects of SKF 38393 with those of other dopamine receptor agonists. Behav Pharmacol 14:223-228.
13. Desai RI, Terry P, Katz JL (2005). A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice. Pharmacol Biochem Behav 81:843-848.
14. Desai RI, Neumeyer JL, Paronis CA, Nguyen P, Bergman J (2007). Behavioral effects of the R-(+)- and S-(-)-enantiomers of the D1-like receptor partial agonist SKF 83959 in monkeys. Eur J Pharmacol (in press).
15. 1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase. Eur J Pharmacol 234:135-136.
16. Elsworth JD, Lawrence MS, Roth RH, Taylor JR, Mailman RB, Nichols DE, et al. (1992). D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey. J Pharmacol Exp Ther 259:595-600.
17. Finney DJ (1964). Statistical method in biological assay. 2nd ed. New York: Hafner.
18. Fornaguera J, Huston JP, Carey RJ, Schwarting RK (1995). Stimulation of D1- or D2-receptors in drug-naive rats with different degrees of unilateral nigrostriatal dopamine lesions. Psychopharmacology 119:145-154.
19. Fujita S, Lee J, Kiguchi M, Uchida T, Cools AR, Waddington JL, Koshikawa N (2006). Topographical resolution of jaw movements mediated by cyclase-versus non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822. Eur J Pharmacol 538:94-100.
20. Gnanalingham KK, Erol D, Hunter A, Smith L, Jenner P, Marsden CA (1995a). Differential anti-parkinsonian effects of benzazepine D1 dompamine agonists with varying efficacies in the MPTP-treated common marmoset. Psychopharmacology 117:275-286.
21. Gnanalingham KK, Hunter AJ, Jenner P, Mardens CD (1995b). Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat: relationship to circling behavior. Biochem Pharm 49:1185-1193.
22. Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD (1995c). The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease. Psychopharmacology 117:287-297.
23. Jutkiewicz EM, Bergman J (2004). Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions. J Pharmacol Exp Ther 311:1008-1015.
24. 1 dopamine receptor agonist, SKF 38393, on behavior maintained by cocaine injection in squirrel monkeys. Psychopharmacology 109:241-244.
25. Katz JL, Kopajtic TA, Myers KA, Mitkus RJ, Chider M (1999). Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys. J Pharmacol Exp Ther 291:265-279.
26. Kebabian JW, Calne DB (1979). Multiple receptors for dopamine. Nature 277:93-96.
27. Kleven MS, Koek W (1996). Differential effects of direct and indirect dopamine agonists on eye blink rate in cynomolgus monkeys. J Pharmacol Exp Ther 279:1211-1219.
28. Makihara Y, Yamamoto H, Inoue M, Tomiyama K, Koshikawa N, Waddington JL (2004). Topographical effects of D1-like dopamine receptor agonists on orofacial movements in mice and their differential regulation via oppositional versus synergistic D1-like: D2-like interactions: cautionary observations on SK and F 82958 as an anomalous agent. J Psychopharmacol 18:484-495.
29. Martin-Iverson MT, Dourish CT (1988). Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats. Psychopharmacology 96:370-374.
30. Munzar P, Goldberg SR (2000). Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 148:209-216.
31. 1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys. Psychopharmacology 160:362-370.
32. Neumeyer JL, Kula NS, Baldessarini RJ, Baindur N (1992). Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepne and its 6-bromo analogue. J Med Chem 35:1466-1471.
33. Neumeyer JL, Kula NS, Bergman J, Baldessarini RJ (2003). Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazpines. Eur J Pharmacol 474:137-140.
34. O'Sullivan GJ, Roth BL, Kinsella A, Waddington JL (2004). SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography. Eur J Pharmacol 486:273-280.
35. Peacock L, Gerlach J (2001). Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions. Biol Psychiatry 50:501-509.
36. Platt DM, Rowlett JK, Spealman RD (2000). Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434. J Pharmacol Exp Ther 293:1017-1026.
37. Platt DM, Rowlett JK, Spealman RD (2001). Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys. Psychopharmacology 157:208-216.
38. Platt DM, Rowlett JK, Spealman RD (2002). Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology 163:265-282.
39. Rusk IN, Cooper SJ (1989). The selective dopamine D1 receptor agonist SK&F 38393: its effects on palatability- and deprivation-induced feeding, and operant responding for food. Pharmacol Biochem Behav 34:17-22.
40. Schindler CW, Carmona GN (2002). Effects of dopamine agonists and antagonists on locomotor activity in male and female rats. Pharmacol Biochem Behav 72:857-863.
41. 1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res. 582:349-352.
42. Sinnott RS, Nader MA (2001). Modulation of cocaine's discriminative stimulus effects by dopamine D(1) agonists in rhesus monkeys. Pharmacol Biochem Behav 68:301-309.
43. Snedecor GW, Cochran WG (1967). Statistical methods. 6th ed. Ames, Iowa: Iowa State University Press. pp. 135-171.
44. Spealman RD, Bergman J, Rosenzweig-Lipson S (1997). Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists. Psychopharmacology 133:283-292.
45. Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV (1999). Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav 64:327-336.
46. 1-receptor agonists on feeding behavior in the rat. Psychopharmacology 109:403-409.
47. 1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 253:987-992.
48. Undie AS, Weinstock J, Sarau HM, Friedman E (1994). Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 622:2045-2048.
49. Wachtel SR, Brooderson RJ, White FJ (1992). Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Psychopharmacology 109:41-48.
50. Waddington JL, Daly SA, Downes RP, Deveney AM, McCauley PG, O'Boyle KM (1995). Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors. Prog Neuropsychopharmacol Biol Psychiatry 19:811-831.
51. Weed MR, Woolverton WL (1995). The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 275:1367-1374.